Retatrutide (GLP-3) is a tri-agonist that targets GLP-1, GIP, and glucagon receptors. Unlike standard GLP-1 agonists, it also stimulates glucagon receptors, enhancing fat metabolism and increasing basal metabolic rate. It regulates appetite and delays gastric emptying, making it a promising candidate for obesity treatment.
10mg - $315
Product Use: This PRODUCT IS INTENDED SOLELY FOR RESEARCH PURPOSES. It is designated for in vitro testing and laboratory experiments only. All information provided on this website is for educational use. The introduction of this substance into humans or animals is illegal. Only licensed and qualified professionals should handle this product. It is not a drug, food, or cosmetic, and must not be misrepresented or misused as one.
